ERG overexpression plus SLC45A3 (prostein) and PTEN expression loss: Strong association of the triple hit phenotype with an aggressive pathway of prostate cancer progression

Por Hernández-Llodrà, Silvia, Juanpere, Nuria, de Muga, Silvia, Lorenzo, Marta, Gil, Joan, Font-Tello, Alba, Agell, Laia, Albero-González, Raquel, Segalés, Laura, Merino, José, Serrano, Laia, Fumadó, Lluís, Cecchini, Lluís, Lloreta-Trull, Josep
Publicado no Oncotarget (2017)

Enhancer-mediated oncogenic function of the menin tumor suppressor in breast cancer

Por Dreijerink, Koen M.A., Groner, Anna C., Vos, Erica S.M., Font-Tello, Alba, Gu, Lei, Chi, David, Reyes, Jaime, Cook, Jennifer, Lim, Elgene, Lin, Charles Y., de Laat, Wouter, Rao, Prakash, Long, Henry, Brown, Myles
Publicado no Cell Rep (2017)

Androgen Receptor Is a Non-canonical Inhibitor of Wild-Type and Mutant Estrogen Receptors in Hormone Receptor-Positive Breast Cancers

Por Ponnusamy, Suriyan, Asemota, Sarah, Schwartzberg, Lee S., Guestini, Fouzia, McNamara, Keely M., Pierobon, Mariaelena, Font-Tello, Alba, Qiu, Xintao, Xie, Yingtian, Rao, Prakash K., Thiyagarajan, Thirumagal, Grimes, Brandy, Johnson, Daniel L., Fleming, Martin D., Pritchard, Frances E., Berry, Michael P., Oswaks, Roy, Fine, Richard E., Brown, Myles, Sasano, Hironobu, Petricoin, Emanuel F., Long, Henry W., Narayanan, Ramesh
Publicado no iScience (2019)

Enhancer signatures stratify and predict outcomes of non-functional pancreatic neuroendocrine tumors

Por Cejas, Paloma, Drier, Yotam, Dreijerink, Koen M. A., Brosens, Lodewijk A. A., Deshpande, Vikram, Epstein, Charles B., Conemans, Elfi B., Morsink, Folkert H. M., Graham, Mindy K., Valk, Gerlof D., Vriens, Menno R., Fernandez-del Castillo, Carlos, Ferrone, Cristina, Adar, Tomer, Bowden, Michaela, Whitton, Holly J., Da Silva, Annacarolina, Font-Tello, Alba, Long, Henry W., Gaskell, Elizabeth, Shoresh, Noam, Heaphy, Christopher M., Sicinska, Ewa, Kulke, Matthew H., Chung, Daniel C., Bernstein, Bradley E., Shivdasani, Ramesh A.
Publicado no Nat Med (2019)